Press Releases

Date Title View
Toggle Summary Second Sight to Discuss Second Quarter 2018 Financial Results on August 7, 2018 Conference Call
LOS ANGELES --(BUSINESS WIRE)--Jul. 31, 2018-- Second Sight Medical Products, Inc. (NASDAQ:EYES), a developer, manufacturer and marketer of implantable visual prosthetics that are intended to create an artificial form of useful vision to blind patients, will release its 2018 second quarter
View HTML
Toggle Summary Second Sight Medical Products, Inc. to Present at the 19th Annual B. Riley FBR Investor Conference
LOS ANGELES --(BUSINESS WIRE)--May 14, 2018-- Second Sight Medical Products, Inc. (NASDAQ: EYES) ("Second Sight" or "the Company"), a developer, manufacturer and marketer of implantable visual prosthetics that are intended to create an artificial form of useful vision to blind patients, today
View HTML
Toggle Summary Second Sight Reports First Quarter 2018 Financial Results
--Orion Feasibility Study on Track with Encouraging Early Results and Four of Five Subjects Implanted -- -- Completed Private Placement of $10 million -- LOS ANGELES --(BUSINESS WIRE)--May 10, 2018-- Second Sight Medical Products, Inc. (NASDAQ:EYES) (“Second Sight” or “the Company”), a developer,
View HTML
Toggle Summary Second Sight Completes $10 Million Private Placement of Common Stock with Gregg Williams, Chairman of the Board of Directors
LOS ANGELES --(BUSINESS WIRE)--May 7, 2018-- Second Sight Medical Products, Inc. (NASDAQ: EYES) ("Second Sight" or "the Company"), a developer, manufacturer and marketer of implantable visual prosthetics that are intended to create an artificial form of useful vision to blind patients, today
View HTML
Toggle Summary Second Sight to Discuss First Quarter 2018 Financial Results on May 10, 2018 Conference Call
LOS ANGELES --(BUSINESS WIRE)--May 3, 2018-- Second Sight Medical Products, Inc. (NASDAQ: EYES), a developer, manufacturer and marketer of implantable visual prosthetics that are intended to create an artificial form of useful vision for blind patients, will release its 2018 first quarter financial
View HTML
Toggle Summary Second Sight Announces Dr. Robert Greenberg’s Resignation from Board of Directors and as an Officer of the Company
LOS ANGELES --(BUSINESS WIRE)--Apr. 9, 2018-- Second Sight Medical Products, Inc. (NASDAQ:EYES) ("Second Sight" or "the Company"), a developer, manufacturer and marketer of implantable visual prosthetics that are intended to create an artificial form of useful vision to blind patients, today
View HTML
Toggle Summary Second Sight Appoints John T. Blake Chief Financial Officer
SYLMAR, Calif. --(BUSINESS WIRE)--Mar. 22, 2018-- Second Sight Medical Products, Inc. (NASDAQ: EYES) ("Second Sight" or "the Company"), a developer, manufacturer and marketer of implantable visual prosthetics that are intended to create an artificial form of useful vision to blind patients, today
View HTML
Toggle Summary Second Sight Appoints Gregg Williams as Chairman of the Board of Directors
SYLMAR, Calif. --(BUSINESS WIRE)--Mar. 16, 2018-- Second Sight Medical Products, Inc. (NASDAQ: EYES) ("Second Sight" or "the Company"), a developer, manufacturer and marketer of implantable visual prosthetics that are intended to create an artificial form of useful vision to blind patients, today
View HTML
Toggle Summary Second Sight Medical Products, Inc. to Present at the B. Riley & Co. China Healthcare Investment Partnering Symposium
SYLMAR, Calif. --(BUSINESS WIRE)--Mar. 8, 2018-- Second Sight Medical Products, Inc. (NASDAQ: EYES) ("Second Sight" or "the Company"), a developer, manufacturer and marketer of implantable visual prosthetics that are intended to create an artificial form of useful vision to blind patients, today
View HTML
Toggle Summary Second Sight Reports Fourth Quarter and Full Year 2017 Financial Results
-- Year-over-year net sales in 2017 double to $8 million , driven by record implant volume -- SYLMAR, Calif. --(BUSINESS WIRE)--Mar. 7, 2018-- Second Sight Medical Products, Inc. (NASDAQ: EYES) ("Second Sight" or "the Company"), a developer, manufacturer and marketer of implantable visual
View HTML